We report what we believe to be an infrequent but noteworthy complication of antiestrogen therapy with tamoxifen. Seven patients developed venous thrombosis or pulmonary embolism within 6 months of starting treatment. Guidelines similar to those employed in younger women treated with anovulatory drugs would appear indicated.